310 related articles for article (PubMed ID: 28838357)
41. The genome clinic: a multidisciplinary approach to assessing the opportunities and challenges of integrating genomic analysis into clinical care.
Bowdin S; Ray PN; Cohn RD; Meyn MS
Hum Mutat; 2014 May; 35(5):513-9. PubMed ID: 24599881
[TBL] [Abstract][Full Text] [Related]
42. Towards precision medicine.
Ashley EA
Nat Rev Genet; 2016 Aug; 17(9):507-22. PubMed ID: 27528417
[TBL] [Abstract][Full Text] [Related]
43. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
Cheng F; Hong H; Yang S; Wei Y
Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
[TBL] [Abstract][Full Text] [Related]
44. [Rare diseases in the age of genomics and precision medicine].
Ríos-Leal JA; Labbé-Atenas TP
Rev Med Chil; 2019 Apr; 147(4):530-531. PubMed ID: 31344219
[No Abstract] [Full Text] [Related]
45. The SickKids Genome Clinic: developing and evaluating a pediatric model for individualized genomic medicine.
Bowdin SC; Hayeems RZ; Monfared N; Cohn RD; Meyn MS
Clin Genet; 2016 Jan; 89(1):10-9. PubMed ID: 25813238
[TBL] [Abstract][Full Text] [Related]
46. Artificial intelligence, physiological genomics, and precision medicine.
Williams AM; Liu Y; Regner KR; Jotterand F; Liu P; Liang M
Physiol Genomics; 2018 Apr; 50(4):237-243. PubMed ID: 29373082
[TBL] [Abstract][Full Text] [Related]
47. Label-free screening of single biomolecules through resistive pulse sensing technology for precision medicine applications.
Harrer S; Kim SC; Schieber C; Kannam S; Gunn N; Moore S; Scott D; Bathgate R; Skafidas S; Wagner JM
Nanotechnology; 2015 May; 26(18):182502. PubMed ID: 25875197
[TBL] [Abstract][Full Text] [Related]
48. Precision Medicine and the Changing Landscape of Research Ethics.
Hammer MJ
Oncol Nurs Forum; 2016 Mar; 43(2):149-50. PubMed ID: 26906126
[TBL] [Abstract][Full Text] [Related]
49. The need for widely available genomic testing in rare eye diseases: an ERN-EYE position statement.
Black GC; Sergouniotis P; Sodi A; Leroy BP; Van Cauwenbergh C; Liskova P; Grønskov K; Klett A; Kohl S; Taurina G; Sukys M; Haer-Wigman L; Nowomiejska K; Marques JP; Leroux D; Cremers FPM; De Baere E; Dollfus H;
Orphanet J Rare Dis; 2021 Mar; 16(1):142. PubMed ID: 33743793
[TBL] [Abstract][Full Text] [Related]
50. Genomic analysis of 63,220 tumors reveals insights into tumor uniqueness and targeted cancer immunotherapy strategies.
Hartmaier RJ; Charo J; Fabrizio D; Goldberg ME; Albacker LA; Pao W; Chmielecki J
Genome Med; 2017 Feb; 9(1):16. PubMed ID: 28231819
[TBL] [Abstract][Full Text] [Related]
51. Nanotechnology: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(19):1-43. PubMed ID: 23074489
[TBL] [Abstract][Full Text] [Related]
52. Genomics and Precision Medicine: Implications for Critical Care.
Kessler C
AACN Adv Crit Care; 2018; 29(1):28-35. PubMed ID: 29496711
[TBL] [Abstract][Full Text] [Related]
53. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
Mack SC; Northcott PA
J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
[TBL] [Abstract][Full Text] [Related]
54. Genomic Common Data Model for Seamless Interoperation of Biomedical Data in Clinical Practice: Retrospective Study.
Shin SJ; You SC; Park YR; Roh J; Kim JH; Haam S; Reich CG; Blacketer C; Son DS; Oh S; Park RW
J Med Internet Res; 2019 Mar; 21(3):e13249. PubMed ID: 30912749
[TBL] [Abstract][Full Text] [Related]
55. Computational methods and translational applications for targeted next-generation sequencing platforms.
Luthra A; Mastrogiacomo B; Smith SA; Chakravarty D; Schultz N; Sanchez-Vega F
Genes Chromosomes Cancer; 2022 Jun; 61(6):322-331. PubMed ID: 35066956
[TBL] [Abstract][Full Text] [Related]
56. Human Microbiome and Learning Healthcare Systems: Integrating Research and Precision Medicine for Inflammatory Bowel Disease.
Chuong KH; Mack DR; Stintzi A; O'Doherty KC
OMICS; 2018 Feb; 22(2):119-126. PubMed ID: 28282257
[TBL] [Abstract][Full Text] [Related]
57. Integrated ACMG-approved genes and ICD codes for the translational research and precision medicine.
Wable R; Nair AS; Pappu A; Pierre-Louis W; Abdelhalim H; Patel K; Mendhe D; Bolla S; Mittal S; Ahmed Z
Database (Oxford); 2023 May; 2023():. PubMed ID: 37195695
[TBL] [Abstract][Full Text] [Related]
58. The Master Protocol Concept.
Redman MW; Allegra CJ
Semin Oncol; 2015 Oct; 42(5):724-30. PubMed ID: 26433553
[TBL] [Abstract][Full Text] [Related]
59. Panomics for Precision Medicine.
Sandhu C; Qureshi A; Emili A
Trends Mol Med; 2018 Jan; 24(1):85-101. PubMed ID: 29217119
[TBL] [Abstract][Full Text] [Related]
60. Opportunities and technical challenges in next-generation sequencing for diagnosis of rare pediatric diseases.
Bacchelli C; Williams HJ
Expert Rev Mol Diagn; 2016 Oct; 16(10):1073-1082. PubMed ID: 27560481
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
